Risk assessment of gastric cancer and Helicobacter pylori may vary depending upon the antibody used;: Anti-CagA specific antibody versus commercial available anti-H-pylori antibody

被引：0
|
作者：
Maeda, S [1 ]
Ogura, K [1 ]
Yoshida, H [1 ]
Yamaji, Y [1 ]
Mitsuno, Y [1 ]
Akanuma, Y [1 ]
Shiratori, Y [1 ]
Omata, M [1 ]
机构：
[1] Univ Tokyo, Tokyo, Japan
来源：
GUT | 1999年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A45 / A46
页数：2
相关论文
共 48 条
  • [1] Risk ratio estimation may vary depending upon the antibody used;: Anti-CagA specific antibody versus commercial available anti-whole H-pylori antibody
    Maeda, S
    Yoshida, H
    Ogura, K
    Yamaji, Y
    Shiratori, Y
    Omata, M
    GASTROENTEROLOGY, 1999, 116 (04) : A242 - A242
  • [2] Analysis of gastric atrophy induced by Helicobacter pylori (H. pylori) infection using serum anti-Helicobacter pylori antibody, anti-Caga antibody, and pepsinogen status
    Yamaji, Y
    Shibata, W
    Watabe, H
    Yanai, A
    Hirata, Y
    Mitsuno, Y
    Maeda, S
    Yoshida, H
    Kawabe, T
    Omata, M
    GASTROENTEROLOGY, 2003, 124 (04) : A424 - A424
  • [3] Antibody response of patients with Helicobacter pylori-related gastric adenocarcinoma:: Significance of anti-CagA antibodies
    Vaucher, C
    Janvier, B
    Nousbaum, JB
    Grignon, B
    Pezennec, L
    Robaszkiewicz, M
    Gouerou, H
    Picard, B
    Fauchere, JL
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2000, 7 (03) : 463 - 467
  • [4] Short half-life of serum anti-CagA antibody:: Comparison with conventional anti-Helicobacter pylori antibody.
    Yoshida, H
    Maeda, S
    Ogura, K
    Kawaguchi, R
    Ikenoue, T
    Kanai, F
    Kawabe, T
    Shiratori, Y
    Omata, M
    GASTROENTEROLOGY, 1998, 114 (04) : A342 - A342
  • [5] Antibody against Helicobacter pylori CagA and VacA and the risk for gastric cancer
    Yamaoka, Y
    Kodama, T
    Kashima, K
    Graham, DY
    JOURNAL OF CLINICAL PATHOLOGY, 1999, 52 (03) : 215 - 218
  • [6] Antibody response of patients with H. pylori related gastric adeno-carcinoma:: Significance of anti-CagA
    Janvier, B
    Vaucher, C
    Nousbaum, JB
    Grignon, B
    Picard, B
    Fauchère, JL
    GUT, 1999, 45 : A72 - A72
  • [7] Assessment of gastric carcinoma risk associated with Helicobacter pylori may vary depending on the antigen used -: CagA specific enzyme-linked immunoadsorbent assay (ELISA) versus commercially available H-pylori ELISAs
    Maeda, S
    Yoshida, H
    Ogura, K
    Yamaji, Y
    Ikenoue, T
    Mitsushima, T
    Tagawa, H
    Kawaguchi, R
    Mori, K
    Mafune, K
    Kawabe, T
    Shiratori, Y
    Omata, M
    CANCER, 2000, 88 (07) : 1530 - 1535
  • [8] Association among anti-CagA antibody detection, antibiotic susceptibility, and peptic ulcer in patients with Helicobacter pylori infection
    Toro, C
    García-Samaniego, J
    Alarcón, T
    Baquero, M
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2003, 21 (03): : 137 - 141
  • [9] Identification of anti East Asian CagA specific antibody in Helicobacter pylori strains of Turkish Origin
    Guvenir, M.
    Uchida, T.
    Perez, G. I. Perez
    Olivares, A. Z.
    Gonen, C.
    Sarioglu, S.
    Soyturk, M.
    Simsek, I.
    Yilmaz, O.
    HELICOBACTER, 2019, 24
  • [10] Serum Helicobacter pylori CagA antibody may not be used as a tumor marker for diagnosing gastric cancer in east Asian countries
    Zhao, Zhicheng
    Li, Yuhong
    Liu, Shengxin
    Fu, Weihua
    TUMOR BIOLOGY, 2014, 35 (12) : 12217 - 12224
12345